Skip to main content

Month: September 2020

Vibe Acquires California Distribution and Manufacturing Assets and Announces Appointment to Board of Directors

SACRAMENTO, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) — Vibe Bioscience Ltd. (CSE:VIBE, OTC:VBSCF, GERMANY:A061) (the “Company” or “Vibe“), a California based cannabis retailer and cultivator, is pleased to announce that, further to the Company’s press release dated August 30, 2020, it has finalized the previously announced transaction (the “Transaction”) to acquire Cathedral Asset Holding Corporation (“CAHC”) and its distribution and manufacturing assets in Santa Rosa, California (“Santa Rosa facility”). Vibe has possession and operational control as of today.  CAHC is a wholly-owned subsidiary of Ventura Cannabis and Wellness Corp. (CSE: VCAN) (“Ventura”).The Santa Rosa facility is licensed for the distribution and manufacturing of regulated cannabis products....

Continue reading

Ventura Cannabis (VCAN) and Vibe Bioscience (VIBE) Close Cathedral Sale

 Not for distribution to United States newswire services or for dissemination in the United States. All figures in canadian dollars unless otherwise specified.LOS ANGELES, Sept. 17, 2020 (GLOBE NEWSWIRE) — Ventura Cannabis and Wellness Corp. (CSE:VCAN) (“Ventura Cannabis”, “VCAN”, or the “Company”) is pleased to announce that it has completed the Company’s sale of Cathedral Asset Holding Corporation (“CAHC” or “Cathedral”) to Vibe Bioscience (CSE:VIBE) (“Vibe”) described in its press release of August 30, 2020.SummaryIn payment of the purchase price, VCAN has been issued 669,398 common shares of Vibe (the “Payment Shares”) which it will distribute to VCAN shareholders shortly. As additional consideration for the sale of Cathedral, Ventura will also receive 800,000 share purchase warrants, each exercisable for one common shares of...

Continue reading

Aravive Appoints Michael W. Rogers to Board of Directors

HOUSTON, Sept. 17, 2020 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing transformative therapeutics, today announced that Michael W. Rogers joined the Company’s Board of Directors. Mr. Rogers is a biopharmaceutical veteran and healthcare leader with more than 20 years of public company financial experience and will serve as a Chair of the Audit Committee and member on the Board’s Business Strategy Committee.“Mr. Rogers’ extensive management and financial experience should be invaluable as we advance Aravive’s clinical programs through development and potential commercialization,” said Gail McIntyre, Ph.D., Chief Executive Officer of Aravive. “His expertise in managing financing strategies, M&A, out-licensing and royalty transactions at both commercial and development-stage...

Continue reading

XPO Logistics to Lead Panel for CILT’s Women in Logistics Virtual Diversity Roadshow

GREENWICH, Conn., Sept. 17, 2020 (GLOBE NEWSWIRE) —  XPO Logistics, Inc. (NYSE: XPO), a leading global provider of transportation and logistics solutions, will be joined by customers Nestlé UK Ltd., Shiseido Company and Ted Baker Plc for a panel discussion on “Relationship-Building in Logistics” at the Women in Logistics UK Virtual Diversity Roadshow on September 23, 2020. The discussion, hosted by the Chartered Institute of Transport and Logistics (CILT), will take place live via Zoom at 13:00 BST (8:00 a.m. EDT).The CILT presents the Women in Logistics UK forum annually to provide professional development opportunities for women in logistics careers. In addition, the forum addresses gender imbalance in the industry and advocates for the inclusion of more diverse talent. XPO is CILT’s partner for this year’s event.Sarah Booth,...

Continue reading

GNR Québec Capital Announces the Appointment of Gérard Mounier as President and General Manager

MONTREAL, Sept. 17, 2020 (GLOBE NEWSWIRE) —  GNR Québec Capital L.P. (“GNR Québec Capital”), an investment fund dedicated to increasing the conversion of waste into renewable natural gas (RNG) in the Province of Québec, is pleased to announce the appointment of Mr. Gérard Mounier as President and General Manager of GNR Quebec Capital Management Inc.Resulting from a partnership announced on June 1st between Xebec Adsorption Inc. (TSXV: XBC) (“Xebec”), a global provider of clean energy solutions, and the Fonds de solidarité FTQ (the “Fonds”), GNR Québec Capital is an innovative fund that provides developers and partners with access to capital and expertise to develop and operate facilities that treat and convert organic waste into renewable natural gas and biofertilizers.“I am particularly proud to...

Continue reading

GNR Québec Capital annonce la nomination de Gérard Mounier à titre de président-directeur général

MONTRÉAL, 17 sept. 2020 (GLOBE NEWSWIRE) — GNR Québec Capital S.E.C. (” GNR Québec Capital “), un fonds d’investissement visant à accroître la transformation des déchets en gaz naturel renouvelable (GNR) dans la province de Québec, est heureuse d’annoncer la nomination de M. Gérard Mounier au poste de président-directeur général de Gestion GNR Québec Capital Inc.Issu d’un partenariat annoncé le 1er juin dernier entre Xebec Adsorption Inc. (TSXV: XBC) (Xebec), fournisseur mondial de solutions d’énergie propre, et le Fonds de solidarité FTQ (Fonds), GNR Québec Capital est un fonds novateur offrant aux promoteurs et aux partenaires l’accès au capital et à l’expertise nécessaires pour développer et exploiter des installations qui traitent et transforment les déchets organiques en gaz naturel renouvelable...

Continue reading

Summit Therapeutics Announces U.K. Court Approval of Scheme

Summit Therapeutics plc(“Summit” or the “Company”)Summit Therapeutics Announces U.K. Court Approval of Scheme; Expects to Complete Redomiciliation to Delaware, USA as of September 18, 2020.Oxford, UK, and Cambridge, MA, US, September 17, 2020 – Summit Therapeutics plc (NASDAQ: SMMT) led by billionaire investor Robert W. Duggan as Executive Chairman, Chief Executive Officer and majority shareholder is pleased to announce that as of September 18, 2020 it expects to complete its redomiciliation to Delaware, USA. Mr Duggan and the Summit Board of Directors extend their appreciation to the High Court of Justice in England and Wales, which sanctioned on September 16, 2020 the scheme of arrangements under Part 26 of the Companies Act of 2006 (the “Scheme”) pursuant to which Summit Therapeutics Inc. will become the new Delaware, USA incorporated...

Continue reading

GasLog Ltd. Announces Appointment of Director

Piraeus, Greece, Sept. 17, 2020 (GLOBE NEWSWIRE) — GasLog Ltd. (“GasLog” or the “Company”) (NYSE: GLOG) announced today that it has appointed Kristin Holth as Independent Director to the Company’s Board of Directors (the “Board”), effective immediately.From 2017 to 2020 Kristin Holth served as Executive Vice President and Global Head of Ocean Industries in DNB Bank ASA, Norway’s largest financial services group. She has significant experience in capital markets and funding and has held numerous management positions within DNB, including Global Head of Shipping, Offshore & Logistics for 4 years and General Manager & Head of DNB Americas for 6 years.Kristin also holds several board positions, including Independent Director of Maersk Drilling since April 2020. She holds a Bachelor in Economics and Business Administration...

Continue reading

OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020

OXFORD BIOMEDICA PLCINTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020Oxford, UK – 17 September 2020: Oxford Biomedica plc (“Oxford Biomedica” or “the Group”) (LSE: OXB), a leading gene and cell therapy group, today announces interim results for the six months ended 30 June 2020.FINANCIAL HIGHLIGHTSRevenue increased by 6% to £34.0 million (H1 2019: £32.1 million)Continued strong growth was seen in bioprocessing and commercial development, where revenues increased by 24% to £23.4 million (H1 2019: £18.8 million)Licences, milestones & royalties were £10.6 million (H1 2019: £13.3 million), a decline of 20% as the growing royalties and licence fee revenue from Juno/BMS in H1 2020 was not able to match the large £11.5 million ($15 million) milestone payment received from Axovant in H1 2019Operating expenses increased by 41% to £29.1million...

Continue reading

Vishay Precision Group to Present at Sidoti Virtual Investor Conference

MALVERN, Pa., Sept. 17, 2020 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leading producer of precision sensors and sensor-based systems, announced that the company’s management will present at the Sidoti Virtual Investor Conference on September 23, 2020 at 9:15AM EDT.  A live webcast, as well as the replay, of this presentation will be accessible from the Investors section of the VPG website at http://ir.vpgsensors.com/events.  In addition, the company is available for one-on-one virtual meetings at the conference.For more information, or to schedule a one-on-one meeting with management, please contact the corporate access coordinators at Sidoti, or email Steve Cantor at VPG’s investor relations department at info@vpgsensors.com.About VPGVishay Precision Group, Inc. is an internationally recognized designer, manufacturer...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.